Results 101 to 110 of about 80,040 (177)

A Mouse-Adapted CHIKV Strain Harboring E2-K200R and Non-Structural Mutations Exhibits Enhanced Pathogenicity in Multiple Rodent Models. [PDF]

Viruses
Tang C, Li B, Huang Q, Yang Y, Yu W, Zhou Y, Wu D, Yang H, Wang H, Wang J, Lu S.   +10 more
europepmc   +1 more source

Insights Into Complex Murine Models of Allergy and Anaphylaxis: The Central Role of IgE and Mast Cells in Advancing Human Therapies. [PDF]

Eur J Immunol
Nagata Y, Suzuki R.
europepmc   +1 more source

C92, a proton channel-blocking allosteric STING agonist generates robust antitumor activity. [PDF]

J Immunother Cancer
Banerjee M, Middya SK, Shrivastava R, Middya A, Pryde DC, Chakraborty D, Soram T, Mane N, Rawat N, Gautam A, Puniya K, Sharma P, Yadav DB, Sônego F, Thiam K, Mills JE, Mani S, Ghosh R, Basu S, Surya A.   +19 more
europepmc   +1 more source

Immunogenicity and Protection of mRNA Vaccine Encoding Spike Protein of SARS-CoV-2 Omicron-XEC Subvariant. [PDF]

Int J Mol Sci
Guan X, Cho H, Liu Q, Qian S, Du L.
europepmc   +1 more source

MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC. [PDF]

J Mol Med (Berl)
Tseng LM, Lau KY, Chen JL, Chu PY, Huang CT, Wang WL, Chang YY, Lai JI, Huang CC, Dai MS, Liu CY.   +10 more
europepmc   +1 more source

Transfusing HPA-mismatched platelets to mimic fetomaternal hemorrhage elicits fetal/neonatal alloimmune thrombocytopenia. [PDF]

Blood
Zhi H, Sheridan D, Newman PJ, Newman DK.
europepmc   +1 more source

Time Course Characterization of Protective Immune Responses Following BCG Vaccination in BALB/c Mice. [PDF]

Pathogens
Kim HH, Kim K, Kim MJ, Yang YJ, Choi EB, Heo JW, Moon SY, Lim H, Lee Y, Ouh IO, Park KI.   +10 more
europepmc   +1 more source

Maternal Krüppel-like factor 2 (KLF2)+ CD4 T cells promote fertility and fetal tolerance. [PDF]

Proc Natl Acad Sci U S A
Nguyen NNM, Brady AE, Russi A, Pham G, Li B, Turner LH, Kotliar M, Barski A, Sun X, Way SS.   +9 more
europepmc   +1 more source

Human Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer and other solid tumors. [PDF]

Sci Rep
Mercogliano MF, Bruni S, De Martino M, Balanian L, Castellano MA, Groisman J, Inserra F, Schillaci R, de Cavanagh EMV.   +8 more
europepmc   +1 more source